Glycobond is a medtech-company founded as a spin-off from research performed at Linköping University.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Linköping
State: Ostergotlands Lan
Zip:
Country: Sweden
Glycobond develops and produces proprietary carbohydrate-binding reagents for use in diagnostics. Glycobond has developed HepaCheC™, an ELISA-based assay that detects aberrant and cancer-specific glycosylation on alpha-1 acid glycoprotein (AGP), an acute phase plasma protein produced mainly in the liver. The protein is secreted into the blood stream why analysis can be performed on a simple blood sample. The method is based on a patented fucose-binding protein, Mono-F, and has shown very promising results in longitudinal analyses of serum samples from patients at risk of developing HCC.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2017 | Grant | 1 | $59.5k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
4/2015 | Venture Round | 1 | - |
Almi Invest Almi Invest |
4/2017 | Venture Round | 1 | - |
LIU Invest LIU Invest |
4/2017 | Venture Round | 1 | - |
LIU Invest LIU Invest |
4/2015 | Venture Round | 1 | - |
Almi Invest Almi Invest |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|